CiTherapeutics

Company Overview

Snapshot

Founded in May 2019 by Saul Kaye, CiTherapeutics operated with 1–10 employees. The company ceased operations in May 2019.

Business overview

CiTherapeutics was a Health Tech & Life Sciences company focused on developing advanced cannabis formulations. The company aimed to bring clinically validated, unique formulations using pharmaceutical-grade delivery systems to market, with an initial product pipeline targeting sleep disorders. It operated within the Pharmaceuticals, Medical Cannabis, and Biotechnology sectors, serving both B2B and consumer markets.

Company Intelligence Q&A

When was CiTherapeutics founded?

CiTherapeutics was founded in May 2019.

Who founded CiTherapeutics?

CiTherapeutics was founded by Saul Kaye.

What was CiTherapeutics' primary focus?

CiTherapeutics focused on bringing advanced cannabis formulations to market, with an initial product focused on sleep disorders.

What was the operational status of CiTherapeutics?

CiTherapeutics ceased to operate in May 2019.

In which sector did CiTherapeutics primarily operate?

CiTherapeutics operated primarily in the Health Tech & Life Sciences sector, specifically within Pharma & Medical Biotechnology and Medical Cannabis.